Literature DB >> 11807220

Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation.

Daniela Gardiol1, Silvina Galizzi1, Lawrence Banks2.   

Abstract

The discs large (Dlg) tumour suppressor protein is targeted for ubiquitin-mediated degradation by the high-risk human papillomavirus E6 proteins. To understand further the mechanisms behind this, a mutational analysis of Dlg was undertaken. This study demonstrates that an intact PDZ domain 2 (PDZ2) on Dlg is necessary for the ability of E6 to bind and degrade Dlg. However, additional residues within the amino-terminal portion of Dlg are also required for optimal E6 activity. Stable cell lines expressing different Dlg mutants were also established and these confirm that Dlg is regulated intrinsically by the proteasome in the absence of E6; however, in this case, the sequences responsible for regulating Dlg stability lie predominantly within PDZ2. These results suggest that there are at least two mechanisms for regulating Dlg protein stability and that the pathways used by E6 are not necessarily the same as those used in the cell in its absence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807220     DOI: 10.1099/0022-1317-83-2-283

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Jonathan W Neidigh; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

2.  Regulation of the DLG tumor suppressor by β-catenin.

Authors:  Vanitha Krishna Subbaiah; Nisha Narayan; Paola Massimi; Lawrence Banks
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

3.  Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.

Authors:  Jayashree Thatte; Lawrence Banks
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

4.  Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.

Authors:  Vjekoslav Tomaic; David Pim; Miranda Thomas; Paola Massimi; Michael P Myers; Lawrence Banks
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.

Authors:  Yi Zhang; Jhimli Dasgupta; Runlin Z Ma; Lawrence Banks; Miranda Thomas; Xiaojiang S Chen
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

6.  The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

Review 7.  Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.

Authors:  Niladri Ganguly; Suraj P Parihar
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

8.  Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.

Authors:  Stephen T Oh; Michelle S Longworth; Laimonis A Laimins
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 9.  Cell polarity proteins: common targets for tumorigenic human viruses.

Authors:  R T Javier
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

10.  Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins.

Authors:  Miranda Thomas; Christian Kranjec; Kazunori Nagasaka; Greg Matlashewski; Lawrence Banks
Journal:  Virol J       Date:  2011-01-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.